DermTech, LLC
PrivateLast Round
Follow-on Offering
Jan 11, 2021
Est. Valuation
$713.1M
Total Funding Raised
$235.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DermTech, LLC is a precision dermatology company that develops and markets non-invasive skin genomics solutions to facilitate the assessment of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermTech, LLC Comparables
Compare DermTech, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Castle Biosciences, Inc. | 74% | |
| SkylineDx | 73% | |
| Scibase Holding | 73% |
For institutional investors. Book with your work email.
DermTech, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jan 11, 2021 | ||||
| PIPE | Mar 4, 2020 | ||||
| Reverse Merger | Aug 29, 2019 | ||||
| Series C | Feb 7, 2018 | ||||
| Series B Extension | Apr 15, 2015 | ||||
Series B | Aug 14, 2013 |
For institutional investors. Book with your work email.
DermTech, LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jacobs Investment Company, LLC | Series A |
| HLM Investment Partners | Reverse Merger |
| Oppenheimer & Co. Inc. | Follow-on Offering |
| William Blair & Company | Follow-on Offering |
| BTIG | Follow-on Offering |
| RTW Investments | Reverse Merger, Series C |
| Craig-Hallum Capital Group | Follow-on Offering |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 87% MoM, from 1.6K to 3K.
- Mar 27, 2025
Monthly visitors increased 121% MoM, reaching 7.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- declares_bankruptcyAug 26, 2026
DermTech, LLC files for Chapter 11 bankruptcy in the District of Delaware in Jun '24 and now liquidates as DTech Liquidating Inc.
For institutional investors. Book with your work email.
DermTech, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DermTech, LLC's valuation, stock price, and market status.
Is DermTech, LLC a public or private company?
DermTech, LLC is a private company.
What is the current stock price of DermTech, LLC?
DermTech, LLC is a private company, so its shares have no public market price. Caplight tracks DermTech, LLC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DermTech, LLC worth (valuation)?
DermTech, LLC's valuation is estimated at $713.1M based on funding round data.
Can I buy DermTech, LLC stock?
DermTech, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DermTech, LLC's last funding round?
DermTech, LLC's most recent funding round was Follow-on Offering on January 11, 2021.
Who are the main investors in DermTech, LLC?
Key investors in DermTech, LLC include William Blair & Company, TD Cowen.
Will DermTech, LLC IPO soon?
No public IPO plans have been announced for DermTech, LLC.
How can I track DermTech, LLC secondary market activity?
Caplight tracks bids, offers, and trades in DermTech, LLC's shares on secondary markets.